Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Follow-On-Biologics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.4% during the forecast period.
This report presents the market size and development trends by detailing the Follow-On-Biologics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Follow-On-Biologics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Follow-On-Biologics industry and will help you to build a panoramic view of the industrial development.
Follow-On-Biologics Market, By Type:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Follow-On-Biologics Market, By Application:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Some of the leading players are as follows:
Teva Pharmaceutical Industries Ltd
LG Life Sciences
Hospira.
Biocon
Merck Serono
Biogen idec Inc.
Synthon Pharmaceuticals, Inc.
Novartis
Celltrion
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Follow-On-Biologics Market: Technology Type Analysis
-
4.1 Follow-On-Biologics Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Follow-On-Biologics Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Human growth hormone
4.3.2 Erythropoietin
4.3.3 Monoclonal antibodies
4.3.4 Insulin
4.3.5 Interferon
4.3.6 Granulocyte-Colony Stimulating Factor
4.3.7 Peptide
5 Follow-On-Biologics Market: Product Analysis
-
5.1 Follow-On-Biologics Product Market Share Analysis, 2018 & 2026
-
5.2 Follow-On-Biologics Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Follow-On-Biologics Market: Application Analysis
-
6.1 Follow-On-Biologics Application Market Share Analysis, 2018 & 2026
-
6.2 Follow-On-Biologics Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Blood disorders
6.3.2 Oncology diseases
6.3.3 Chronic and autoimmune diseases
6.3.4 Growth hormone deficiencies
7 Follow-On-Biologics Market: Regional Analysis
-
7.1 Follow-On-Biologics Regional Market Share Analysis, 2018 & 2026
-
7.2 Follow-On-Biologics Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Teva Pharmaceutical Industries Ltd
9.1.1 Teva Pharmaceutical Industries Ltd Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 LG Life Sciences
9.2.1 LG Life Sciences Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Hospira.
9.3.1 Hospira. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Biocon
9.4.1 Biocon Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Merck Serono
9.5.1 Merck Serono Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Biogen idec Inc.
9.6.1 Biogen idec Inc. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Synthon Pharmaceuticals, Inc.
9.7.1 Synthon Pharmaceuticals, Inc. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Novartis
9.8.1 Novartis Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Celltrion
9.9.1 Celltrion Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
The List of Tables and Figures (Totals 85 Figures and 135 Tables)
Figure Human growth hormone Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Erythropoietin Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Monoclonal antibodies Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Insulin Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Interferon Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Granulocyte-Colony Stimulating Factor Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Peptide Follow-On-Biologics market, 2015 - 2026 (USD Million)
Figure Blood disorders market, 2015 - 2026 (USD Million)
Figure Oncology diseases market, 2015 - 2026 (USD Million)
Figure Chronic and autoimmune diseases market, 2015 - 2026 (USD Million)
Figure Growth hormone deficiencies market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Follow-On-Biologics market, by country, 2015 - 2026 (USD Million)
-
Table North America Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table North America Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table North America Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Canada Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Canada Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Europe Follow-On-Biologics market, by country, 2015 - 2026 (USD Million)
-
Table Europe Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Europe Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Europe Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Germany Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Germany Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table France Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table France Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Italy Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Italy Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Spain Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Spain Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Follow-On-Biologics market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table China Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table China Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Japan Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Japan Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table India Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table India Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Follow-On-Biologics market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table MEA Follow-On-Biologics market, by country, 2015 - 2026 (USD Million)
-
Table MEA Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table MEA Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table MEA Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Follow-On-Biologics market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Follow-On-Biologics market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Follow-On-Biologics market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Teva Pharmaceutical Industries Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table LG Life Sciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hospira. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biocon Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Serono Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biogen idec Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Synthon Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celltrion Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
